These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30232933)

  • 1. Non-interventional study of the safety and effectiveness of fluticasone propionate/formoterol fumarate in real-world asthma management.
    Backer V; Ellery A; Borzova S; Lane S; Kleiberova M; Bengtsson P; Tomala T; Basset-Stheme D; Bennett C; Lindner D; Meiners A; Overend T
    Ther Adv Respir Dis; 2018; 12():1753466618796987. PubMed ID: 30232933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting β
    Price DB; Carter V; Martin J; Gardener EA; Skinner D; Yang S; Hoffman M; Willis JC; Cooper AJ
    Drugs; 2020 Jan; 80(1):47-60. PubMed ID: 31749061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial.
    Płoszczuk A; Bosheva M; Spooner K; McIver T; Dissanayake S
    Ther Adv Respir Dis; 2018; 12():1753466618777924. PubMed ID: 29857783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An innovative corticosteroid/long-acting β
    Usmani O; Roche N; Marshall J; Danagher H; Price D
    Expert Opin Drug Deliv; 2019 Dec; 16(12):1367-1380. PubMed ID: 31752560
    [No Abstract]   [Full Text] [Related]  

  • 5. Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler - Results from a non-interventional study.
    Schmidt O; Petro W; Hoheisel G; Kanniess F; Oepen P; Langer-Brauburger B
    Respir Med; 2017 Oct; 131():166-174. PubMed ID: 28947024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of comparative treatment effects with high and low dose fluticasone propionate/formoterol combination in asthma.
    Dissanayake S; Jain M; Grothe B; McIver T; Papi A
    Pulm Pharmacol Ther; 2015 Dec; 35():19-27. PubMed ID: 26474679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.
    Balki A; Balamurugan S; Bardapurkar S; Dalal S; Singh A; Singh BP; Vaidya A; Gogtay JA
    Pulm Pharmacol Ther; 2018 Feb; 48():28-36. PubMed ID: 28890299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety and efficacy of fluticasone/formoterol combination therapy in asthma.
    Mansur AH; Kaiser K
    J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):190-9. PubMed ID: 23098325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A PHASE III STUDY TO EVALUATE SAFETY AND EFFICACY OF FLUTICASONE/FORMOTEROL COMBINATION (FLUTIFORM
    Katsunuma T; Kamata M; Ishikawa Y
    Arerugi; 2020; 69(5):341-352. PubMed ID: 32684549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations.
    Papi A; Mansur AH; Pertseva T; Kaiser K; McIver T; Grothe B; Dissanayake S
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):346-61. PubMed ID: 27104231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer® in patients with persistent asthma in India.
    Ghoshal A; Waghray P; Dsouza G; Saluja M; Agarwal M; Goyal A; Limaye S; Balki A; Bhatnagar S; Jain M; Tikkiwal S; Vaidya A; Lopez M; Hegde R; Gogtay J
    Pulm Pharmacol Ther; 2020 Feb; 60():101869. PubMed ID: 31794836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: a pooled analysis.
    Papi A; Price D; Sastre J; Kaiser K; Lomax M; McIver T; Dissanayake S
    Respir Med; 2015 Feb; 109(2):208-17. PubMed ID: 25575940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Persistence to treatment and resources use with inhaled fixed-dose combinations of corticosteroids and long-acting β-adrenergic agonists for the treatment of asthma: A population-based retrospective study].
    Sicras-Mainar A; Traseira-Lugilde S; Fernández-Sánchez T; Navarro-Artieda R
    Semergen; 2018 Oct; 44(7):472-484. PubMed ID: 29545018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform(®)) for the treatment of asthma.
    Tan RA; Corren J
    Drug Des Devel Ther; 2014; 8():1555-61. PubMed ID: 25328383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma.
    Corren J; Mansfield LE; Pertseva T; Blahzko V; Kaiser K
    Respir Med; 2013 Feb; 107(2):180-95. PubMed ID: 23273405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revising old principles of inhaled treatment in new fixed combinations for asthma.
    Scichilone N; Rossi A; Melani A
    Pulm Pharmacol Ther; 2015 Aug; 33():32-8. PubMed ID: 26079566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world effects of two inhaled corticosteroid/long-acting β₂-agonist combinations in the treatment of asthma.
    Yatera K; Yamasaki K; Nishida C; Noguchi S; Oda K; Akata K; Nagata S; Kawanami Y; Kawanami T; Ishimoto H; Mukae H
    J Asthma; 2014 Sep; 51(7):762-8. PubMed ID: 24654703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler.
    Latorre M; Paggiaro P; Canonica W; Foschino MP; Papi A
    Pulm Pharmacol Ther; 2015 Oct; 34():31-6. PubMed ID: 26278189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.